Could a prostate drug ease bladder troubles for women with MS?
NCT ID NCT07614321
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether silodosin, a drug typically used for enlarged prostate, can help women with multiple sclerosis who have bothersome urinary symptoms. Sixty female participants will take either silodosin or a placebo daily for 8 weeks. Researchers will use symptom questionnaires and urine flow tests to see if the drug provides relief.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- silodosin
- What this could lead to
- If it works, this could offer a new medication option for women with MS who struggle with bladder control.
- What could go wrong
- This is a small, early-phase trial with only 60 participants. The drug may not work better than a placebo, and side effects like dizziness or low blood pressure are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOWER URINARY TRACK SYMPTOMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Atlantic Health
RECRUITINGMorristown, New Jersey, 07960, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we decode the different types of pain in multiple sclerosis?
- Can a blood pressure pill slow MS disability?
- Hidden MS progression: can brain scans and blood tests predict it?
- Can Brain-Training apps fix sleep in MS?
- Can an Iron-Based dye reveal hidden inflammation in progressive MS?
- Strumming for the brain: could ukulele lessons sharpen minds in MS?